期刊文献+

辛伐他汀治疗高脂血症60例临床观察 被引量:2

下载PDF
导出
摘要 目的探讨辛伐他汀治疗混合型高脂血症的临床效果。方法选择60例总胆固醇(TC)≥6.5mmol/L或三酰甘油(TG)≥1.7mmol/L或低密度脂蛋白胆固醇(LDL-C)≤2mmol/L患者,给予辛伐他汀20mg,1次/d,晚间顿服,于用药8周后分别测定血脂四项、血常规、肝肾功能、丙氨酸转氨酶(ALT)、肌酸磷酸激酶(CK)等。结果治疗前后血脂有显著变化,未发现明显不良反应。结论辛伐他汀治疗高脂血症效果显著,不良反应小,对预防心血管疾病有实际意义。
作者 赵光 张敏
出处 《中国医药指南》 2009年第21期70-71,共2页 Guide of China Medicine
  • 相关文献

参考文献5

二级参考文献32

  • 1[1]Scandinavian Simvastatin Sur vival Study Group.Randomized trial of ch olesterol lowering in 4444 patients with coronary heart disease:the Scandinavan Simvastatin Survival Study(4S). Lancet,1994,344:1383-1389.
  • 2[2]The long-term Intervention with P ravastatin in Ischemic Disease(LIPID )Stud y Group.Prevention of cardiovascular eve nts and death with pravastatin in patien ts with coronary heart disease and a bro ad rang of initial cholesterol levels.N Engl J Med,1998,339:1349-1357.
  • 3[3]Forrester JS.Role of plaque ruptu re in acute coronary syndromes.Am J Card iol,2000,86(suppl.):155-235.
  • 4[4]Selwyn AP,Kinlay S,Libby P,et al .Atherogenic lipids,vascular dysfunction ,and clinical signs of ischemic heart di sease.Circulation,1997,95:5-7.
  • 5[5]Dupuis J,Tardif JC,Cernacek P,et al.Cholesterol reduction rapidly improve s endothelium function after acute coron ary syndrome:the RECIFE(Reduction of Cho lesterol in Ischemia and Function of the Endothelium)trial[see comm ents].[ BFQ〗Circulation,1999,99:3227-3233.
  • 6[6]ODriscoll G,Green D,Taylor RR.Simvast atin an HMG-coenzyme a reductase inhibit or,improves endothelial function within 1 month.Circulation,1997,95:1126-1131.
  • 7[7]Treasure CB,Klein JL,Weintraub WS ,et al.Beneficial effects of cholesterol -lowering therapy on the coronary endoth elium in patients with coronary artery d isease.N Engl Med,1995,332:481-487.
  • 8[8]Niwa S,Totsuka Y,Hayshi S.Inhibit ory effect of fluvastatin,an HMG-CoA red uctase inhibitor,on the expression of ad hesion molecules on human monocytes cell line.Int J Immunopharmacol,1996,18:669- 675.
  • 9[9]Bustos C,Hernandez-Presa MA,Ortego M,e t al.HMG-CoA reductase inhibition by ato rvastatin reduces neointimal inflammatio n in a rabbit model of atherosclerosis.J Am Coll Cardiol,1998,32:2057-2064.
  • 10[10]Albert MA,Danielson E,Rifai N,et al.Effect of statin therapy on creactiv e protein levels:the pravastatin inflamm ation/CRP evaluation(PRINCE):a randomizen trial and cohort study.JAMA,2 001,286:64-70.

共引文献52

同被引文献50

  • 1陈小容,聂本刚.阿托伐他汀钙对血管性认知障碍合并高脂血症患者的血脂及认知功能的影响[J].中国全科医学,2009,12(15):1382-1384. 被引量:31
  • 2王玉花.阿托伐他汀引起过敏反应1例[J].中南药学,2005,3(1):51-51. 被引量:7
  • 3李明,冯堃,张涛.口服调脂药致横纹肌溶解症1例[J].药物流行病学杂志,2006,15(3):186-186. 被引量:10
  • 4戴亦晖,王小虹.氟伐他汀钠致急性胃绞痛[J].药物不良反应杂志,2006,8(5):383-383. 被引量:4
  • 5Schaefer E J.HMG-CoA reductase inhibitorsfor hypercholesteroLemia.N Engl J Mad,1998.319:122.
  • 6Bonovas S,Sitaras N M.Does pravastatin promote cancer in elderly patients? a meta-analysis.CMAJ,2007,176 (5):649.
  • 7Mo H,Elson C E.Studies of the Isoprenoid mediated Inhibition of Meralonate Syuthesis Applied to Cancer Chemotherapy and Chemopravention.Exp Biol Med,2004,229(6):567.
  • 8Steiner S,Gaflin C L,Lennon J J,et al.Cholesterol biosynthesis regu lation and pro-tein changes in rat liver following treatmentwith fluvastatin.Toxicol Lett,2001,120(1-3):369.
  • 9Deodwania P,Stone PH,Baircy Merz C N,et al.Effects of intensive versus moderate lipid-lowering therapy on myocardial ischemia in older patients with coronary heart disease:resultsof the Study Assessing Goals in the Elderly(SAGE).Circulation,2007,115 (6):700.
  • 10Law M,Rudnieka A R.Stutin safety:a systematic review.Am JCardiol,2006,97 (8A):52C.

引证文献2

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部